Shelf-life Extension of Azacitidine: Waste and Cost Reduction in the Treatment of Myelodysplastic Syndromes | Aplastic Anemia & MDS International Foundation Return to top.

Shelf-life Extension of Azacitidine: Waste and Cost Reduction in the Treatment of Myelodysplastic Syndromes

Journal Title: 
Leuk Lymphoma
Primary Author: 
Guirguis HR
Author(s): 
Guirguis HR, Charbonneau LF, Tyono I, Wells RA, Cheung MC, Buckstein R
Original Publication Date: 
Saturday, May 31, 2014

No abstract available.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.